What Next for Pfizer's Medical Device Business
Executive SummaryIt didn't take a crystal ball to foresee Pfizer's recent announcement that it is looking to exit the medical device business. But the question is, How? Finding a buyer for its diverse cardiovascular, orthopedics and urological businesses is slim. The concensus among industry executives: Pfizer will try spinning the businesses out into a public corporation, following a strategy Lilly used very successfully with Guidant Corp.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.